Medical Research

Peer-reviewed scientific developments act as the primary defense against medical misinformation, providing patients with evidence-based guidelines for managing their health. While the month of October is widely recognized for its vibrant pink ribbons and awareness campaigns, August 18 marks a more

Internal friction is mounting within the White House as President Trump reportedly grows impatient with the pace of the research mission led by Secretary Kennedy and his circle of political appointees. This frustration stems from a fundamental shift in the federal approach to childhood

Established scientific evidence is being replaced by political intuition, leading to what many experts describe as a "war on public health" that threatens the nation's youngest citizens. This shift manifested recently through a controversial executive directive requiring the dismantling of the

Capital is currently concentrating on high-cost chronic conditions, with cardiovascular disease and nephrology startups securing hundreds of millions in funding as healthcare systems seek to reduce long-term management expenses. This strategic pivot reflects a broader shift within the European

Citius Pharmaceuticals is leveraging a staggering 86 percent overall response rate from Phase 1 trials of LYMPHIR as a pretreatment for CAR-T therapy in large B-cell lymphoma. This clinical success arrives at a pivotal moment as the company navigates the complex transition from a research-oriented

The first sixty seconds of a newborn's life outside the womb constitute a physiological pivot point where every intervention carries profound weight for long-term health and developmental stability. Recent insights published in the Journal of Perinatology suggest that the traditional hurry to clamp